Hrt Financial LP Essa Pharma Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.15 - $7.94 $168,345 - $424,337	53,443 New	53,443 $168,000
Q4 2021 Feb 14, 2022	SELL	$7.8 - $14.38 $578,658 - $1.07 Million	-74,187 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $575,691 - $2.18 Million	74,187 New	74,187 $593,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $594,968 - $843,836	-24,616 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.61 - $32.08 $285,791 - $789,681	24,616 New	24,616 $715,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $74M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.